Cargando…
Lactobacillus fermentum CECT5716 Alleviates the Inflammatory Response in Asthma by Regulating TLR2/TLR4 Expression
BACKGROUND: Asthma is a chronic disease, which is harmful to the health of the body and the quality of life. Supplementation of Lactobacillus can affect the immune environment of the lungs through the gut-lung axis. This study aimed to explore the potential regulatory targets of Lactobacillus to rel...
Autores principales: | Wang, Weifang, Li, Yunfeng, Han, Guojing, Li, Aimin, Kong, Xiaomei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331901/ https://www.ncbi.nlm.nih.gov/pubmed/35911120 http://dx.doi.org/10.3389/fnut.2022.931427 |
Ejemplares similares
-
Limosilactobacillus fermentum CECT5716: Mechanisms and Therapeutic Insights
por: Rodríguez-Sojo, María Jesús, et al.
Publicado: (2021) -
Beneficial Effects of Limosilactobacillus fermentum CECT 5716 Administration to Infants Delivered by Cesarean Section
por: Blanco-Rojo, Ruth, et al.
Publicado: (2022) -
Study protocol: evaluation of the probiotic Lactobacillus Fermentum CECT5716 for the prevention of mastitis in breastfeeding women: a randomised controlled trial
por: Bond, Diana M., et al.
Publicado: (2017) -
Oral Administration to Nursing Women of Lactobacillus fermentum CECT5716 Prevents Lactational Mastitis Development: A Randomized Controlled Trial
por: Hurtado, José A., et al.
Publicado: (2017) -
Lactobacillus fermentum CECT5716 Supplementation in Rats during Pregnancy and Lactation Impacts Maternal and Offspring Lipid Profile, Immune System and Microbiota
por: Azagra-Boronat, Ignasi, et al.
Publicado: (2020)